UID:
almahu_9950000946202882
Umfang:
XXVII, 634 p. 126 illus., 123 illus. in color.
,
online resource.
Ausgabe:
1st ed. 2025.
ISBN:
9783031817878
Inhalt:
Drug development stands at a transformative threshold in modern medicine. Over the past three decades, biotherapeutics have redefined medical innovation, paving the way for treatments that are not only effective but also accessible. This book provides a comprehensive exploration of the intricate world of drug development, shedding light on the essential balance between efficiency, regulatory compliance, and quality to achieve both innovation and affordability. Written by leading experts, this guide delves into the multi-faceted process of drug development, covering critical areas such as pharmacology, biomarkers, toxicology, product development, manufacturing, and clinical trials-all framed within the stringent requirements set by the FDA. Readers will find in-depth discussions on the latest technologies, statistical approaches, and quality assurance measures essential to navigating today's complex regulatory landscape. With practical case studies, project reports, and curated article reviews, this book offers valuable insights into risk assessment and mitigation at every stage of development. It serves as an indispensable resource for students, educators, and industry professionals, aiming to foster a deeper understanding of the challenges and opportunities in drug development and to inspire the next generation of scientific innovators.
Anmerkung:
Foreword 1 -- Foreword 2 -- Life Cycle of Drug Development -- Vaccines as prophylactics and therapeutics -- Discovery of Biologic Drugs: past, present, and future -- Cellular Therapies: from a theoretical concept to an immuno-augmented reality -- Hope Unlocked: Gene therapies with viral vectors and Gene Editing -- Process development for biologic therapeutics -- Manufacturing of biologic therapeutics -- Pharmacology of protein based therapeutics -- The role of biomarkers in clinical development and its relevance in precision medicines -- Examining the Toxicological Landscape of New Molecular Entities and Biotherapeutics -- Perspective on Clinical Trials: What Researchers need to know -- From Orphan Drugs to Inclusive Research: Bridging Global Gaps in Rare Disease Treatment -- N=1: development pipeline for rare diseases -- What Entrepreneurs Need to Know About Intellectual Property When Building a Strong Patent Portfolio -- The power of Data Analytics: manufacturing Quality & Compliance -- Quality Risk Analysis - the key to failure prevention -- Regulatory Strategy -- Epilogue -- APPENDIX.
In:
Springer Nature eBook
Weitere Ausg.:
Printed edition: ISBN 9783031817861
Weitere Ausg.:
Printed edition: ISBN 9783031817885
Weitere Ausg.:
Printed edition: ISBN 9783031817892
Sprache:
Englisch
DOI:
10.1007/978-3-031-81787-8
URL:
https://doi.org/10.1007/978-3-031-81787-8
URL:
Volltext
(URL des Erstveröffentlichers)
Bookmarklink
